Age-related Macular Degeneration (AMD) Market Size Worth $14.43 Billion By 2030 | CAGR: 7.9%

𝐓𝐡𝐞 𝐚𝐠𝐞-𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐦𝐚𝐜𝐮𝐥𝐚𝐫 𝐝𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 (𝐀𝐌𝐃) 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟕.𝟒𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟏 𝐚𝐧𝐝 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟏𝟒.𝟒𝟑 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟑𝟎, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟕.𝟗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟐 𝐭𝐨 𝟐𝟎𝟑𝟎.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧
A chronic eye condition called age-related macular degeneration (AMD) gradually impairs vision in the center of the eye. One of the main reasons why older adults lose their vision is AMD. It happens when aging damages, the macula, the area of the retina that regulates central vision. The main symptoms of AMD include difficulty in seeing faces or fine prints, changes in color perception, blurred vision, experiencing some blank spots in your vision, and straight lines that might appear to be wavy or crooked. AMD condition is of two different types, which are dry AMD and wet AMD.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/global-age-related-macular-degeneration-amd-market/request-for-sample

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬
• The age-related macular degeneration (AMD) market is expanding largely due to rising R&D expenditures and more and more new drug approvals.
• As the world's population increases and the demographics show that the majority of people are older, the prevalence of AMD is continuing to rise at an unprecedented rate.
• Another major contributor to the market growth and the growing prevalence of AMD in the world today is increased cigarette consumption and tobacco use.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬
In this extremely competitive market, major rivals constantly innovate and differentiate their products in an effort to take the lead in the market. Here's the list of a few of the major key players involved in the market:
Acucela Inc.
Alimera Sciences Inc.
ALLERGAN
Bausch & Lomb Incorporated
Bayer AG
F. Hoffmann La Roche
GlaxoSmithKline PLC
Novartis AG
Ophthotech Corporation
Pfizer Inc

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
https://www.polarismarketresearch.com/buy/118/0

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
The age-related macular degeneration market is segmented basically depending on products, drugs, route of administration, distribution channels used, and region. In the global market for age-related macular degeneration (AMD), the wet AMD segment is anticipated to generate the largest revenue contribution based on product segment.
Since AMD is the most common cause of significant vision loss in people over 50, the growing global geriatric population is creating a high level of demand in the wet age-related macular degeneration market.

𝐀𝐠𝐞-𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐌𝐚𝐜𝐮𝐥𝐚𝐫 𝐃𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 (𝐀𝐌𝐃), 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤
• Wet AMD
• Dry AMD

𝐀𝐠𝐞-𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐌𝐚𝐜𝐮𝐥𝐚𝐫 𝐃𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 (𝐀𝐌𝐃), 𝐃𝐫𝐮𝐠𝐬 𝐎𝐮𝐭𝐥𝐨𝐨𝐤
• Lucentis
• Eylea
• Avastin
• Others

𝐀𝐠𝐞-𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐌𝐚𝐜𝐮𝐥𝐚𝐫 𝐃𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 (𝐀𝐌𝐃), 𝐑𝐨𝐮𝐭𝐞 𝐨𝐟 𝐀𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐎𝐮𝐭𝐥𝐨𝐨𝐤
• Intravenous
• Intravitreal

𝐀𝐠𝐞-𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐌𝐚𝐜𝐮𝐥𝐚𝐫 𝐃𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 (𝐀𝐌𝐃), 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐭𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/global-age-related-macular-degeneration-amd-market

𝐆𝐞𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜𝐚𝐥 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

o North America (U.S., Canada)
o Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
o Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
o Latin America (Brazil, Mexico, Argentina)
o Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Hemophilia A Treatment Market
https://www.polarismarketresearch.com/industry-analysis/hemophilia-a-treatment-market

Hemodynamic Monitoring Devices Market
https://www.polarismarketresearch.com/industry-analysis/global-hemodynamic-monitoring-devices-market

Narcolepsy Therapeutics Market
https://www.polarismarketresearch.com/industry-analysis/global-narcolepsy-therapeutics-market

Ultrasound Devices Market
https://www.polarismarketresearch.com/industry-analysis/ultrasound-devices-market

Bipolar Disorder Treatment Market
https://www.polarismarketresearch.com/industry-analysis/global-bipolar-disorder-treatment-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.